News

The American Heart Association published a report from the Target: AS Registry examining quality metrics for evaluation, surveillance, and management of aortic stenosis patients. The registry aims to establish benchmarks and identify gaps in AS care delivery across participating centers.

Digest: This AHA registry provides standardized quality measures that can guide institutional protocols for AS patient management and inform appropriate timing for intervention referrals.

A high-intensity ultrasound technology designed to treat calcified valve leaflets has launched in Europe. No specific clinical data or device details were provided in the article content.

Digest: Novel leaflet modification technologies could expand treatment options for calcified valves, though clinical validation data are needed to assess utility in structural heart interventions.

Badano et al published a letter to the editor commenting on a previously published article examining exercise right ventricular-pulmonary arterial coupling as a prognostic marker in primary mitral regurgitation. This correspondence addresses methodological or interpretive aspects of the original research on RV-PA coupling assessment during exercise in mitral regurgitation patients.

Digest: Exercise RV-PA coupling may inform patient selection and timing decisions for transcatheter or surgical mitral valve interventions in primary mitral regurgitation.

This is a correspondence response by Moura-Ferreira et al addressing a previously published article on the prognostic value of exercise right ventricular-pulmonary arterial coupling in primary mitral regurgitation. The response provides commentary or additional perspective on the original research findings regarding RV-PA coupling assessment during exercise in MR patients.

Digest: Exercise RV-PA coupling assessment may refine risk stratification and surgical timing decisions in primary mitral regurgitation patients, particularly those with preserved left ventricular function.

A new guideline has been published to standardize echocardiographic guidance protocols for mitral transcatheter edge-to-edge repair (M-TEER) procedures. The guideline aims to harmonize imaging practices across operators and centers performing M-TEER interventions.

Digest: Standardized echo guidance protocols can improve procedural outcomes, reduce variability in M-TEER technique, and establish benchmarks for quality assurance in this growing mitral valve intervention field.

The Society of Cardiovascular Computed Tomography (SCCT) 2026 annual meeting featured presentations focused on plaque imaging techniques, artificial intelligence applications, and structural heart disease. The conference highlighted advances in CT-based cardiac imaging modalities relevant to structural interventions.

Digest: SCCT conference coverage demonstrates the growing integration of advanced CT imaging and AI tools in pre-procedural planning and risk stratification for structural heart interventions.

TAVR valve implant depth significantly influences post-procedural outcomes including paravalvular leak, conduction abnormalities requiring permanent pacemaker, and coronary obstruction risk. Optimal implantation depth varies by valve platform, with higher implantation generally associated with reduced paravalvular regurgitation but increased pacemaker rates, while deeper implantation may increase coronary occlusion risk particularly in valve-in-valve procedures.

Digest: Precise implant depth optimization is a modifiable procedural factor that directly impacts major TAVR complications and may influence valve selection and procedural planning across risk stratifications.

The American Heart Association awarded $15 million to three research centers (Mass General Brigham, Cincinnati Children's Hospital, and University of Pittsburgh) to establish a Strategically Focused Research Network on Earlier Detection and Delaying Progression of Valvular Heart Disease. The four-year initiative addresses a growing global health burden affecting over 80 million people worldwide and contributing to more than 57,000 deaths annually in the U.S.

Digest: This dedicated funding network may accelerate discovery of biomarkers and diagnostic tools for pre-symptomatic valve disease detection, potentially expanding the treatable patient population before irreversible cardiac remodeling occurs.

University of Colorado Hospital's Heart and Vascular Center performs approximately 3,000 interventional and structural heart procedures annually, including complex PCI with hemodynamic support and transcatheter mitral valve repair. The program has participated in pivotal trials for structural heart devices and performs 25-50 chronic total occlusion procedures and 50 Impella-supported high-risk PCI cases per year.

Digest: This academic center's experience with MitraClip procedures, complex high-risk PCI, and participation in pivotal device trials provides insights into advanced structural heart program development and procedural volumes at high-performing institutions.